Cai, Xiaoling
Hu, Dayi
Pan, Changyu
Li, Guangwei
Lu, Juming
Ji, Qiuhe
Su, Benli
Tian, Haoming
Qu, Shen http://orcid.org/0000-0003-0811-7070
Weng, Jianping
Zhang, Danyi
Xu, Jie
Ji, Linong
Funding for this research was provided by:
Bristol-Myers Squibb (China), CCMR-NEW2D study
Article History
Received: 22 October 2018
Accepted: 9 May 2019
First Online: 22 May 2019
Competing Interests
: Linong Ji has received fees for lecture presentations from AstraZeneca, Merck, Novartis, Lilly, Roche, Sanofi-Aventis and Takeda. Linong Ji has received consulting fees from companies including AstraZeneca, Merck, Novartis, Lilly, Roche, Sanofi-Aventis and Takeda. Linong Ji has received grants/research support from AstraZeneca, Bristol-Myers Squibb, Merck, Novartis, and Sanofi-Aventis. There are no other disclosures for other authors.